Renal denervation in patients who do not respond to cardiac resynchronization therapy

Cardiac resynchronization therapy (CRT) reduces the morbidity and mortality in advanced heart failure (HF) in about two-thirds of the patients. Approximately one-third of the patients do not respond to CRT. The overactivity of sympathetic nervous system is associated with advanced HF and deteriorates the hemodynamic state. We tested the hypothesis that controlling sympathetic overactivity by renal denervation (RDN) could be beneficial in nonresponders for CRT. In our HeartF-RDN study (ClinalTrials.gov. NCT02638324), RDN could not reverse the progression of HF in subjects with New York Heart Association Classification (NYHA) III-IV stage symptoms.

Medienart:

E-Artikel

Erscheinungsjahr:

2022

Erschienen:

2022

Enthalten in:

Zur Gesamtaufnahme - volume:56

Enthalten in:

Scandinavian cardiovascular journal : SCJ - 56(2022), 1 vom: 09. Dez., Seite 103-106

Sprache:

Englisch

Beteiligte Personen:

Pietilä-Effati, Päivi [VerfasserIn]
Höglund, Mathias [VerfasserIn]
Käräjämäki, Aki [VerfasserIn]
Höglund, Filip [VerfasserIn]
Nabb, Anne-Maria [VerfasserIn]
Matila, Eija [VerfasserIn]
Koistinen, M Juhani [VerfasserIn]

Links:

Volltext

Themen:

6-minute walking test
CRT nonresponder
Cardiac resynchronization therapy
Heart failure
Journal Article
Renal sympathetic denervation

Anmerkungen:

Date Completed 20.05.2022

Date Revised 09.06.2022

published: Print

Citation Status MEDLINE

doi:

10.1080/14017431.2022.2060526

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM341099252